Larry underwent a radical prostatectomy when he was first diagnosed with prostate cancer at age 62. Although the surgery was successful in removing the cancer, about 8 years later, he found his PSA levels began to rise, indicating his cancer may have returned. This came as a shock to Larry, but he was ready to tackle his cancer once again. His treatment plan included radiation and hormone therapy.

As a patient with advanced prostate cancer, and an extensive family history including relatives with prostate, bladder, and gastric cancers, his doctor recommended he take the Myriad MyRisk® Hereditary Cancer Test. This test analyzes a person’s DNA for genetic mutations passed down through their family that may have caused their cancer. Tests like MyRisk can also identify a patients risk of developing a second cancer, and can qualify patients for advanced therapies and clinical trials.

Larry, his wife and three children

Larry’s MyRisk test results showed he had a positive PMS2 mutation that is associated with Lynch Syndrome, a mutation that increases a person’s risk of developing colon cancer.

With this new information, Larry now undergoes increased screenings and colonoscopies to detect any potential early signs of colon cancer. Knowing he’s a carrier of this genetic mutation, he has encouraged his three children to also get tested and take preventive measures. Larry was grateful for the MyRisk test, saying “I wish I had known about it sooner; I would have gotten tested with no hesitation.”

Larry’s experience highlights the critical information genetic testing can provide about an individual’s cancer risk. It is essential for those with a high risk or a family history of cancer to undergo testing. Larry’s proactive approach to his health demonstrates the importance of acting and advocating for better answers.

Act now. Find out if you qualify for MyRisk Hereditary Cancer Testing.

Medical societies strongly recommend genetic testing if you meet any of the following criteria:

Request a MyRisk test kit today!